GB1483650A - Pharmaceutical preparations based on mesterolone - Google Patents

Pharmaceutical preparations based on mesterolone

Info

Publication number
GB1483650A
GB1483650A GB39140/74A GB3914074A GB1483650A GB 1483650 A GB1483650 A GB 1483650A GB 39140/74 A GB39140/74 A GB 39140/74A GB 3914074 A GB3914074 A GB 3914074A GB 1483650 A GB1483650 A GB 1483650A
Authority
GB
United Kingdom
Prior art keywords
mesterolone
pharmaceutical preparations
preparations based
sept
ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB39140/74A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of GB1483650A publication Critical patent/GB1483650A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)

Abstract

1483650 Compositions containing mesterolone SCHERING AG 6 Sept 1974 [6 Sept 1973] 39140/74 Heading A5B A pharmaceutical preparation for use in the treatment of depressive symptoms, which is in unit dosage form comprises mesterolone, and/or a 17-ester thereof, in admixture or conjunction with a pharmaceutically suitable carrier, the total quantity of mesterolone and/or 17-ester in each dosage unit form being at least 30 mg.
GB39140/74A 1973-09-06 1974-09-06 Pharmaceutical preparations based on mesterolone Expired GB1483650A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732345376 DE2345376A1 (en) 1973-09-06 1973-09-06 PHARMACEUTICAL PREPARATION II

Publications (1)

Publication Number Publication Date
GB1483650A true GB1483650A (en) 1977-08-24

Family

ID=5892030

Family Applications (1)

Application Number Title Priority Date Filing Date
GB39140/74A Expired GB1483650A (en) 1973-09-06 1974-09-06 Pharmaceutical preparations based on mesterolone

Country Status (4)

Country Link
US (1) US3908007A (en)
DE (1) DE2345376A1 (en)
GB (1) GB1483650A (en)
NL (1) NL7411859A (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4415591A (en) * 1981-06-04 1983-11-15 Georgia Tech Research Institute Use of aminoalkyl phenyl sulfide derivatives for the treatment of hypertension
US5883087A (en) * 1991-01-07 1999-03-16 Pherin Corporation Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
DE4218292C1 (en) * 1992-06-03 1994-02-03 Mattern Et Partner Pharmazeuti Use of a medicinal product containing mestanolone and / or 4-chloro-1-dehydromethyltestosterone
CN1057531C (en) * 1993-06-15 2000-10-18 弗林公司 Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical
EP0711169B1 (en) * 1993-06-15 2003-12-10 Pherin Corporation Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US20090093513A1 (en) * 2007-10-09 2009-04-09 Hamann Mark T Method to Use Compositions Having Antidepressant Anxiolytic and Other Neurological Activity and Compositions of Matter
BE1027858B1 (en) * 2019-12-13 2021-07-14 Georges Debled Pharmaceutical composition for contraception in women

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1152100B (en) * 1960-12-23 1963-08-01 Schering Ag Process for the preparation of 1ª ‡ -Methyl-3-ketosteroids
DE1122944B (en) * 1960-04-06 1962-02-01 Schering Ag Process for the preparation of 1ª ‡ -Methyl-3-ketosteroids

Also Published As

Publication number Publication date
NL7411859A (en) 1975-03-10
US3908007A (en) 1975-09-23
DE2345376A1 (en) 1975-03-20

Similar Documents

Publication Publication Date Title
GB2213484B (en) New derivatives of 17beta-oh 19-nor steroids substituted in the 17 alpha position, their preparation, their use as medicaments and pharmaceutical compositions
DE3067252D1 (en) Cyclopeptides and pharmaceutical preparations thereof, process for their preparation and their use
PH12097A (en) Pharmaceutically active pepiide and composition thereof
GB1483650A (en) Pharmaceutical preparations based on mesterolone
IL51586A (en) 3-oxo-17 beta-hydroxy-17 alpha-hydroxypropyl androstane and estrane derivatives,process for their preparation and pharmaceutical preparations containing them
GB1457546A (en) Pharmaceutical preparations comprising cephalosporin derivatives
DE3067790D1 (en) Pharmacologically active peptides, their preparation and pharmaceutical compositions containing them
DE3380166D1 (en) Pharmaceutical composition containing a fibrinolytic agent and a diffusion factor, useful for the treatment of the myocardium infarction
GB1488995A (en) Compositions containing anti-androgenic compounds
GB1474749A (en) Pharmaceutical preparations based on cyproterone
AU476979B2 (en) 4'-alkoxyalkyleneoxy-5-benzylpyrimidines, their preparation and pharmaceutical compositions thereof
IL45344A0 (en) 16alpha-methyl-pregna-1,4,9(11)-triene-3,20-diones as medicaments,new processes for the preparation of these products,and pharmaceutical compositions
AU476623B2 (en) 3 7-hydroxy-19-nor-5d-pregnane-11, 20-dione and pharmaceutical compositions thereof
DE2967070D1 (en) 11,17-substituted pregnanes, their preparation and application for the preparation of pharmaceutical compositions
GB1214712A (en) Contraceptive preparations
GB1459485A (en) Medicament pack for the oral treatment with oestrogen
IE41296L (en) 2', 3'-DIHYDROESTRA-1, 3, 5(10)-TRIENO-(16Ó, 17Ó-b)¹FURAN-17ß-OLS.
CA874437A (en) 18-METHYL-9.beta.,10.alpha.-STEROIDS OF THE ANDROSTANE SERIES, METHODS OF PRODUCING THE SAME, PHARMACEUTICAL PREPARATIONS CONTAINING SAID COMPOUNDS AS ACTIVE INGREDIENTS AND METHODS OF PRODUCING THE SAID PREPARATIONS
GB1475651A (en) Pharmaceutical composition for the treatment of cancer
GB1449043A (en) Treatment of asthma
IL47859A (en) 3-(4'-oxo-l-rhamnosyl)-14 hydroxy-bufa-4,20,22-trienolide,its preparation and pharmaceutical compositions containingthem
GB1294538A (en) Pharmaceutical compositions
GB1446615A (en) Pharmaceutical compositions containing an anti-allergy drug
GB1312204A (en) Pharmaceutical compositions
GB1358136A (en) Glucocorticoid-like water diuretic and anti-inflammatory compositions

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee